What departments does Molecular Partners have?

Molecular Partners has employees across 12 departments including Entrepreneurship, Operations, Information Technology, Product Management, Program & Project Management.

What is the largest department at Molecular Partners?

The largest department at Molecular Partners is Research with 5 employees.

Where are Molecular Partners employees located globally?

Molecular Partners has employees across 2 continents and 10 countries including Switzerland, United Kingdom Of Great Britain And Northern Ireland, Poland, France, Germany.

How has Molecular Partners's team size changed over time?

Molecular Partners's team has decreased from approximately 189 to 138 employees based on available data.

Molecular Partners Employee Directory

Q: Who are Molecular Partners's key employees and leadership?

Molecular Partners's key employees include: Ceo: P. A., Chief Scientific Officer: M. S., Chief Medical Officer: P. L., Chief Operating Officer: A. Z., Vice President Head Of New Product Planning L Biopharmaceuticals L Oncology: K. D..

Biotechnology ResearchZurich, Switzerland51-200 Employees

Molecular Partners AG is a clinical-stage biotechnology company that designs and develops DARPin therapeutics, a distinct class of customized protein therapeutics intended to address medical challenges not readily tackled by other approaches. The firm is headquartered in Zurich, Switzerland, and maintains an office in Concord, Massachusetts, with a pipeline spanning preclinical and clinical development concentrated on oncology. It pursues its own proprietary programs and also enters into collaborations with major pharmaceutical companies to deliver these therapies to patients.

Founded in 2004, Molecular Partners operates from its Swiss and U.S. locations. Recent activity includes partnerships to enable development and manufacturing of Radio-DARPin therapeutics, including a collaboration with Eckert & Ziegler Isotope Products GmbH. The company has reported clinical progress and conference engagement in 2026, including MP0712, a dll3-targeting Radio-DARPin currently dosing in a Phase 1 study, presented at ASCO and SNMMI.

Molecular Partners Global Highlights

Europe
157

Switzerland
144
Germany
4
United Kingdom Of Great Britain And Northern Ireland
3
Poland
2
France
1
Netherlands
1
Belgium
1
Norway
1

North America
6

United States Of America
5
Guatemala
1

Molecular Partners's Leadership

P. A.
Ceo
Mobile Phone
Email
M. S.
Chief Scientific Officer
Mobile Phone
Email
P. L.
Chief Medical Officer
Mobile Phone
Email
A. Z.
Chief Operating Officer
Mobile Phone
Email
K. D.
Vice President Head Of New Product Planning L Biopharmaceuticals L Oncology
Mobile Phone
Email
V. K.
Vice President Development Project Leader
Mobile Phone
Email
R. C.
Vp Clinical Development
Mobile Phone
Email
M. K.
Vp Intellectual Property, Head Of Ip
Mobile Phone
Email

Molecular Partners Employee Metrics

100%

50%

0%

2026

2025

Research
Quality Assurance
Program & Project Management
Operations
Engineering
Other
Legal
Information Technology
Biotechnology
Administrative
Business
Human Resources
Product Management
Pharmaceuticals
Accounting

Contact profiles from Molecular Partners

Name

Title

Contact

Location

Last Update

M. K.
Vp Intellectual Property, Head Of Ip
Mobile Phone
Email
SwitzerlandZurich
Jul 31, 2026
V. C.
Vice President Research & Discovery
Mobile Phone
Email
SwitzerlandZurich
Aug 20, 2026
M. S.
Head Drug Safety
Mobile Phone
Email
SwitzerlandBasel-City
Jul 06, 2026
K. D.
Vice President Pharmacology
Mobile Phone
Email
SwitzerlandZurich
Mar 07, 2026
O. V.
Head Of Bioanalytics
Mobile Phone
Email
United Kingdom
Mar 04, 2024
B. J.
Director, Outsourcing And Vendor Management
Mobile Phone
Email
PolandMazovia
Aug 28, 2026
L. J.
Director, Portfolio Management & Communications
Mobile Phone
Email
SwitzerlandZurich
Aug 18, 2026
K. I.
Associate Director, Translational Medicine
Mobile Phone
Email
SwitzerlandZurich
Apr 14, 2026
C. L.
Senior Director Radiotherapeutics
Mobile Phone
Email
SwitzerlandZurich
Aug 28, 2026
M. B.
Associate Director Oncology Research | Group & Biology Lead
Mobile Phone
Email
SwitzerlandZurich
Aug 18, 2026

Frequently Asked Questions

What is Molecular Partners known for?

Molecular Partners was founded in 2004 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at

+41-44-755-7****

. Explore Molecular Partners's company overview page for more information.

What is Molecular Partners's most common email format?

Molecular Partners employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Molecular Partners email formats with LeadIQ.

How many employees does Molecular Partners have currently?

Molecular Partners has approximately 142 employees as of August 2026. These team members are located across 2 continents, including EuropeNorth America.

Who are Molecular Partners's key employees and leadership?

As of August 2026, Molecular Partners's key employees include:

Ceo: P. A.
Chief Scientific Officer: M. S.
Chief Medical Officer: P. L.
Chief Operating Officer: A. Z.
Vice President Head Of New Product Planning L Biopharmaceuticals L Oncology: K. D.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Molecular Partners Employee Directory

Find Molecular Partners employees' phone numbers or email addresses

Name search is limited — try advanced search instead